72040-13-2

Upstream product

• 945756-44-5 C₁₇H₁₈N₂O₄ 
• 619-10-3 5-nitro-2-chlorophenol 
• 76464-61-4 1-chloro-4-nitro-2-(phenylmethoxy)benzene 
• 110-91-8 morpholine 
• 52427-05-1 2-bromo-5-nitrophenol 

Downstream Products

• 3062-54-2 4-[2-(2-morpholin-4-yl-ethoxy)-4-nitro-phenyl]-morpholine 
• 1093798-70-9 C₁₆H₂₂N₂O₆ 
• 1093798-71-0 C₁₆H₂₄N₂O₄*ClH 
• 1093799-97-3 C₂₄H₃₁N₇O₅ 
• 1093799-95-1 C₂₉H₃₉N₇O₇ 

Relevant academic research and scientific papers

AMINOTRIAZOLES FOR THE TREATMENT OF DEMYELINATING DISEASES

The invention relates to triazole compounds of formula (I') or pharmaceutically acceptable salts thereof, useful as modulators of demyelinating diseases: wherein A is selected from the group consisting of (i), (ii), (iii), (iv), (v), and (vi) The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention, methods of using the compositions and kits thereof in the treatment of various demyelinating and neurodegenerative diseases, including multiple sclerosis.

INDOLIN-2-ONES AND AZA-INDOLIN-2-ONES

The present invention relates to compounds or pharmaceutically-acceptable salts thereof, processes for preparing them, pharmaceutical compositions containing them and their use in therapy. The invention particularly relates to certain indolin- 2-ones and aza-indolin-2-ones which possess anti-tumour activity and are accordingly useful in methods of treatment of the human or animal body, in particular such compounds are useful in the treatment of pathological processes which involve an aberrant cellular proliferation, such as tumor growth, rheumatoid arthritis, restenosis and atherosclerosis.